References
- Kaboli PJ, Hoth AB, McClimon MD, et al. Clinical pharmacists and inpatient medical care: A systematic review. Arch Internal Med. 2006;166(9):955–964.
- Stowasser D, Collins D, Stowasser M. A randomised controlled trial of medication liaison services—patient outcomes. J Pharm Pract Res. 2002;32(2):133–140.
- Perez A, Doloresco F, Hoffman JM, et al. Economic evaluations of clinical pharmacy services: 2001–2005. Pharmacotherapy. 2009;29(1):128.
- Gallagher J, McCarthy S, Byrne S. Economic evaluations of clinical pharmacist interventions on hospital inpatients: a systematic review of recent literature. Int J Clin Pharm. 2014;36(6):1101–1114.
- Tully MJ, Seston EM. Impact of pharmacists providing a prescription review and monitoring service in ambulatory care or community practice. Ann Pharmacother. 2000;34:11.
- Schumock GT, Butler MG, Meek PD, et al. Evidence of the economic benefit of clinical pharmacy services: 1996–2000. Pharmacotherapy. 2003;23(1):113–132.
- Gallagher J, McCarthy S, Woods N, et al. Economic evaluation of a randomized controlled trial of pharmacist-supervized patient self-testing of warfarin therapy. J Clin Pharm Ther. 2015;40(1):14–19.
- Myers B, Mitchell C, Whitty J, et al. Prescribing and medication communication on the post-take ward round. Intern Med J. 2017;47:454–457.
- Society of Hospital Pharmacists of Australia. SHPA standards of practice for clinical pharmacy services. J Pharm Pract Res. 2013;43:2.
- Lane D, Ferri M, Lemaire J, et al. A systematic review of evidence-informed practices for patient care rounds in the ICU*. Crit Care Med. 2013;41(8):2015–2029.
- Miller G, Franklin BD, Jacklin A. Including pharmacists on consultant-led ward rounds: a prospective non-randomised controlled trial. Clin Med. 2011;11(4):312–316.
- Touchette DR, Doloresco F, Suda KJ, et al. Economic evaluations of clinical pharmacy services: 2006–2010. Pharmacotherapy. 2014;34(8):771–793.
- Schumock GT, Meek PD, Ploetz PA, et al. Economic evaluations of clinical pharmacy services–1988–1995. The publications committee of the American College of Clinical Pharmacy. Pharmacotherapy. 1996;16(6):1188–1208.
- Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. Jama Internet. 1999;282(3):267–270.
- Fertleman M, Barnett N, Patel T. Improving medication management for patients: the effect of a pharmacist on post-admission ward rounds.[Erratum appears in Qual Saf Health Care. 2005 Aug;14(4):312]. Qual Saf Health Care. 2005;14(3):207–211.
- Soric MM, Glowczewski JE, Lerman RM. Economic and patient satisfaction outcomes of a layered learning model in a small community hospital. Am J Health Syst Pharm. 2016;73(7):456–462.
- Bednal R, McRobbie D, Russell SJ. Prospective evaluation of pharmacy services to post-take ward rounds. Pharm J. 2003;271:22–23.
- Lal LS, Anassi EO, McCants E. Documentation of the first steps of pediatric pharmaceutical care in a county hospital. Hosp Pharm. 1995;30(12):1107–8, 11–2.
- Yee DK, Veal JH, Trinh B, et al. Involvement of HMO-based pharmacists in clinical rounds at contract hospitals. Am J Health Syst Pharm. 1997;54(6):670–673.
- White C, Moses S. Cost impact and clinical benefits of focused rounding in the cardiovascular intensive care unit. Hosp Pharm. 1998;33:4.
- Weekes H. Hospital pharmacy practice: US versus UK. Tomorrow's Pharmacist, Tomorrow's pharmacist. June 2014, online | URI: 11138998. Accessed March 2019.